NEW YORK, April 24 /CNW/ -- PulmoBioTech Inc. (OTC Bulletin Board: PLMO)
announced today that its PulmoScience subsidiary has released details of the
areas that it will be investigating as part of the Regulatory Approval
Experiments for Human Trials.
